Spruce Biosciences's total assets for Q3 2025 were $15.31M, a decrease of -29.82% from the previous quarter. SPRB total liabilities were $9.93M for the fiscal quarter, a 14.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.